X0306 4 2023-02-17 0000887359 Vericel Corp VCEL 0001626325 Hopper Jonathan Mark C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2023-02-18 4 M 0 2325 0 A 52522 D Common Stock 2023-02-18 4 F 0 1108 29.82 D 51414 D Common Stock 2023-02-19 4 M 0 1750 0 A 53164 D Common Stock 2023-02-19 4 F 0 752 29.82 D 52412 D Stock Option (Right to Buy) 29.82 2023-02-17 4 A 0 1875 0 A 2033-02-17 Common Stock 1875 1875 D Stock Option (Right to Buy) 29.82 2023-02-17 4 A 0 28125 0 A 2033-02-17 Common Stock 28125 28125 D Restricted Stock Unit 2023-02-17 4 A 0 12000 0 A Common Stock 12000 12000 D Restricted Stock Unit 2023-02-18 4 M 0 2325 D Common Stock 2325 6975 D Restricted Stock Unit 2023-02-19 4 M 0 1750 D Common Stock 1750 3500 D The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 18, 2022. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026. These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on February 19, 2021. The remaining RSUs will vest in annual installments on February 19, 2024 and February 19, 2025. These options shall begin vesting on February 17, 2023 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period. Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 17, 2024. The remaining RSUs will vest in annual installments on February 17, 2025, February 17, 2026, and February 17, 2027, respectively. No expiration date for this type of award. The Fair Market Value of the vested derivative securities is $29.82 per share. /s/ Sean Flynn, as Attorney-in-Fact for Jonathan Hopper 2023-02-22